Published in Curr Opin Lipidol on June 01, 2007
The metabolic syndrome. Endocr Rev (2008) 5.33
Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study. Arch Intern Med (2009) 1.94
IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol (2010) 1.67
Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr (2010) 1.57
Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38
A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice. J Clin Biochem Nutr (2008) 1.24
Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes. Diabetes (2008) 1.20
Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans. Obesity (Silver Spring) (2008) 1.14
Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine (2013) 1.03
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release. Diabetes Care (2013) 1.03
The role of adipose tissue in mediating the beneficial effects of dietary fish oil. J Nutr Biochem (2010) 1.02
Hyperuricaemia and the metabolic syndrome in type 2 DM. Diabetol Metab Syndr (2010) 0.99
Insulin-resistance and metabolic syndrome are related to executive function in women in a large family-based study. Eur J Epidemiol (2010) 0.99
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability. Mediators Inflamm (2008) 0.99
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis (2013) 0.98
Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis (2011) 0.98
Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARγ-adiponectin pathway. PLoS One (2013) 0.95
Bofutsushosan, an Oriental Herbal Medicine, Attenuates the Weight Gain of White Adipose Tissue and the Increased Size of Adipocytes Associated with the Increase in Their Expression of Uncoupling Protein 1 in High-Fat Diet-Fed Male KK/Ta mice. J Clin Biochem Nutr (2008) 0.94
Associations of SNPs in ADIPOQ and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis (MESA). Obesity (Silver Spring) (2010) 0.93
Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med (2012) 0.92
Disulfide-dependent self-assembly of adiponectin octadecamers from trimers and presence of stable octadecameric adiponectin lacking disulfide bonds in vitro. Biochemistry (2009) 0.90
Adipokines and hepatic insulin resistance. J Diabetes Res (2013) 0.88
Lipophilic micronutrients and adipose tissue biology. Nutrients (2012) 0.88
Systematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian Population. Int J Med Sci (2016) 0.88
Metabolic syndrome, adipokines and ghrelin in overweight and obese schoolchildren: results of a 1-year lifestyle intervention programme. Eur J Pediatr (2010) 0.87
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). J Diabetes Complications (2013) 0.84
Adiponectin and IGFBP-1 in the development of gestational diabetes in obese mothers. BMJ Open Diabetes Res Care (2014) 0.83
Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study. Metab Syndr Relat Disord (2012) 0.82
Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation. Oncotarget (2013) 0.82
The activities of lysyl hydroxylase 3 (LH3) regulate the amount and oligomerization status of adiponectin. PLoS One (2012) 0.81
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo. Am J Physiol Endocrinol Metab (2011) 0.81
Simvastatin suppresses dexamethasone-induced secretion of plasminogen activator inhibitor-1 in human bone marrow adipocytes. BMC Musculoskelet Disord (2011) 0.81
Effect of adiponectin gene polymorphisms on waist circumference in patients with diabetes. J Diabetes Metab Disord (2012) 0.81
Arsenite activates NFκB through induction of C-reactive protein. Toxicol Appl Pharmacol (2012) 0.80
Differential effects of energy balance on experimentally-induced colitis. World J Gastroenterol (2012) 0.80
ADIPOQ single nucleotide polymorphism: Association with adiponectin and lipoproteins levels restricted to men. Meta Gene (2015) 0.80
Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in mice. Metabolism (2013) 0.80
Gene expression identifies heterogeneity of metastatic behavior among high-grade non-translocation associated soft tissue sarcomas. J Transl Med (2014) 0.79
Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit. Diabetes (2014) 0.79
The aporphine alkaloid boldine induces adiponectin expression and regulation in 3T3-L1 cells. J Med Food (2009) 0.79
Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr (2013) 0.79
Hypoadiponectinemia in obesity: association with insulin resistance. Indian J Clin Biochem (2012) 0.78
Relationship between inflammation biomarkers, antioxidant vitamins, and bone mineral density in patients with metabolic syndrome. Nutr Res Pract (2011) 0.78
Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and Women. PLoS One (2015) 0.77
EPA prevents fat mass expansion and metabolic disturbances in mice fed with a Western diet. J Lipid Res (2016) 0.77
Association of adiponectin and metabolic syndrome in adolescents: the caspian- III study. J Diabetes Metab Disord (2015) 0.77
Expression of plasma membrane receptor genes during megakaryocyte development. Physiol Genomics (2013) 0.77
Extracellular conversion of adiponectin hexamers into trimers. Biosci Rep (2012) 0.77
Adiponectin, Insulin Sensitivity and Diabetic Retinopathy in Latinos With Type 2 Diabetes. J Clin Endocrinol Metab (2015) 0.76
Adiponectin and risk of vascular events in the Northern Manhattan study. Atherosclerosis (2012) 0.76
PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome. Proc Natl Acad Sci U S A (2016) 0.76
Promoting effect of triterpenoid compound from Agrimonia pilosa Ledeb on preadipocytes differentiation via up-regulation of PPARγ expression. Pharmacogn Mag (2015) 0.76
Linking adiponectin and autophagy in the regulation of breast cancer metastasis. J Mol Med (Berl) (2014) 0.76
AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity. Biochem Biophys Res Commun (2013) 0.76
Retrospective analysis of metabolic syndrome: prevalence and distribution in executive population in urban pakistan. Int J Family Med (2012) 0.75
Impact of Major Depressive Disorder on Prediabetes by Impairing Insulin Sensitivity. J Diabetes Metab (2016) 0.75
Skeletal Muscle TRIB3 Mediates Glucose Toxicity in Diabetes and High- Fat Diet-Induced Insulin Resistance. Diabetes (2016) 0.75
Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and β-catenin signaling. Biochem Biophys Res Commun (2016) 0.75
Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: an analysis of the ESPECIAL trial. BMC Nephrol (2015) 0.75
Assessment of adiponectin level in obese and lean Nepalese population and its possible correlation with lipid profile: A cross-sectional study. Indian J Endocrinol Metab (2013) 0.75
AACE comprehensive diabetes management algorithm 2013. Endocr Pract (2013) 4.88
American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract (2012) 3.29
Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes (2006) 3.14
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2016 EXECUTIVE SUMMARY. Endocr Pract (2016) 3.01
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) (2013) 2.22
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation. J Lipid Res (2005) 2.18
Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One (2010) 2.14
Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care (2004) 2.11
Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort. Invest Ophthalmol Vis Sci (2004) 1.89
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet (2013) 1.82
Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacology (2006) 1.60
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages. Atherosclerosis (2002) 1.59
Use of HbA1c for diagnoses of diabetes and prediabetes: comparison with diagnoses based on fasting and 2-hr glucose values and effects of gender, race, and age. Metab Syndr Relat Disord (2014) 1.53
Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. Blood Cells Mol Dis (2004) 1.52
The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle. Endocrine (2007) 1.44
Aace/Ace comprehensive diabetes management algorithm 2015. Endocr Pract (2015) 1.43
Polymorphism in the transcription factor 7-like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women. Diabetes (2006) 1.39
Intracellular lipid accumulation in liver and muscle and the insulin resistance syndrome. Endocrinol Metab Clin North Am (2008) 1.38
Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care (2012) 1.35
NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem (2007) 1.33
Adiponectin reduces lipid accumulation in macrophage foam cells. Atherosclerosis (2008) 1.31
Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int (2003) 1.30
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care (2008) 1.27
Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metabolism (2008) 1.26
Genome-wide association of body fat distribution in African ancestry populations suggests new loci. PLoS Genet (2013) 1.24
Mitochondrial DNA (mtDNA) haplotypes reveal maternal population genetic affinities of Sea Island Gullah-speaking African Americans. Am J Phys Anthropol (2005) 1.23
Intramyocellular lipid and insulin resistance: differential relationships in European and African Americans. Obesity (Silver Spring) (2011) 1.23
Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care (2003) 1.22
The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity. Obesity (Silver Spring) (2013) 1.21
Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes (2010) 1.19
Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach. J Clin Endocrinol Metab (2004) 1.17
Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes. Diabetes Res Clin Pract (2002) 1.16
Adiponectin multimers and metabolic syndrome traits: relative adiponectin resistance in African Americans. Obesity (Silver Spring) (2008) 1.14
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort. Diabetes Care (2003) 1.12
Genome-wide linkage scan in Gullah-speaking African American families with type 2 diabetes: the Sea Islands Genetic African American Registry (Project SuGAR). Diabetes (2008) 1.10
Type 2 diabetes associated changes in the plasma non-esterified fatty acids, oxylipins and endocannabinoids. PLoS One (2012) 1.09
Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. Am J Physiol Endocrinol Metab (2009) 1.08
Role of extrathyroidal TSHR expression in adipocyte differentiation and its association with obesity. Lipids Health Dis (2012) 1.06
Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes. Diabetes (2003) 1.06
Estimation of resting energy expenditure considering effects of race and diabetes status. Diabetes Care (2004) 1.02
The clinical approach to the detection of lipodystrophy - an AACE consensus statement. Endocr Pract (2013) 1.02
Three novel mtDNA restriction site polymorphisms allow exploration of population affinities of African Americans. Hum Biol (2003) 1.02
Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance. Metab Syndr Relat Disord (2014) 1.01
Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study. J Lipid Res (2010) 1.00
Gene-centric meta-analysis of lipid traits in African, East Asian and Hispanic populations. PLoS One (2012) 0.99
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages. Atherosclerosis (2013) 0.98
Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses. Atherosclerosis (2011) 0.98
Mitochondrial DNA genetic diversity among four ethnic groups in Sierra Leone. Am J Phys Anthropol (2005) 0.98
Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression. Neurobiol Learn Mem (2012) 0.97
Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction. Biochemistry (2006) 0.95
Troglitazone antagonizes metabolic effects of glucocorticoids in humans: effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin. Diabetes (2002) 0.93
Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages. Atherosclerosis (2005) 0.92
Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications (2005) 0.92
Entero-insular axis and postprandial insulin differences in African American and European American children. Am J Clin Nutr (2008) 0.91
BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans. Diabetes (2013) 0.91
Skeletal muscle lipid peroxidation and insulin resistance in humans. J Clin Endocrinol Metab (2012) 0.90
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract (2017) 0.90
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes. Endocr Pract (2010) 0.89
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. J Diabetes Complications (2008) 0.88
Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia. J Psychiatr Res (2008) 0.88
Epigallocatechin-3-gallate prevents TNF-α-induced NF-κB activation thereby upregulating ABCA1 via the Nrf2/Keap1 pathway in macrophage foam cells. Int J Mol Med (2012) 0.87
Antagonism of betulinic acid on LPS-mediated inhibition of ABCA1 and cholesterol efflux through inhibiting nuclear factor-kappaB signaling pathway and miR-33 expression. PLoS One (2013) 0.87
A clustering analysis of lipoprotein diameters in the metabolic syndrome. Lipids Health Dis (2011) 0.86
Advances in the Science, Treatment, and Prevention of the Disease of Obesity: Reflections From a Diabetes Care Editors' Expert Forum. Diabetes Care (2015) 0.86
VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids. PLoS One (2013) 0.86
MicroRNA-467b targets LPL gene in RAW 264.7 macrophages and attenuates lipid accumulation and proinflammatory cytokine secretion. Biochimie (2012) 0.86
Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques. J Cardiovasc Pharmacol (2006) 0.86
Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes. Nutr Metab (Lond) (2006) 0.86
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. Endocr Pract (2016) 0.86
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract (2015) 0.85
Type 2 diabetes with partial lipodystrophy of the limbs: a new lipodystrophy phenotype. Diabetes Care (2013) 0.85
Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. J Atheroscler Thromb (2012) 0.85
Dietary adherence during weight loss predicts weight regain. Obesity (Silver Spring) (2010) 0.85
OxLDL up-regulates Niemann-Pick type C1 expression through ERK1/2/COX-2/PPARα-signaling pathway in macrophages. Acta Biochim Biophys Sin (Shanghai) (2012) 0.85
A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes. Diabetes Technol Ther (2010) 0.85
Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction. Metab Syndr Relat Disord (2012) 0.84
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning. J Appl Physiol (1985) (2010) 0.84
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review). J Diabetes Complications (2013) 0.84
TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway. Diabetes (2013) 0.83
Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes. Nutrition (2008) 0.83
Role of TRIB3 in regulation of insulin sensitivity and nutrient metabolism during short-term fasting and nutrient excess. Am J Physiol Endocrinol Metab (2012) 0.82
Role of UCP2 and UCP3 in nutrition and obesity. Nutrition (2004) 0.82
Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study. Endocr Pract (2010) 0.82
A complications-based clinical staging of obesity to guide treatment modality and intensity. Curr Opin Endocrinol Diabetes Obes (2013) 0.81